MGTA Annual ROE
-72.16%
-30.96%-75.15%
31 December 2022
Summary:
As of January 21, 2025, MGTA annual return on equity is -72.16%, with the most recent change of -30.96% (-75.15%) on December 31, 2022. During the last 3 years, it has fallen by -17.79% (-32.72%).MGTA ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
MGTA Quarterly ROE
-71.92%
+2.72%+3.64%
30 June 2023
Summary:
As of January 21, 2025, MGTA quarterly return on equity is -71.92%, with the most recent change of +2.72% (+3.64%) on June 30, 2023. Over the past year, it has dropped by -24.52% (-51.73%).MGTA Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
MGTA ROE Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -75.2% | -51.7% |
| 3 y3 years | -32.7% | -29.9% |
| 5 y5 years | -2.3% | -58.6% |
MGTA ROE High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | ||||
| 5 y | 5-year | ||||
| alltime | all time | +82.7% | +79.8% |
Magenta Therapeutics ROE History
| Date | Annual | Quarterly |
|---|---|---|
| June 2023 | - | -71.92%(-3.6%) |
| Mar 2023 | - | -74.64%(+26.1%) |
| Dec 2022 | -72.16%(+75.1%) | -59.18%(+14.2%) |
| Sept 2022 | - | -51.80%(+9.3%) |
| June 2022 | - | -47.40%(+10.8%) |
| Mar 2022 | - | -42.77%(+4.4%) |
| Dec 2021 | -41.20%(-20.9%) | -40.98%(-2.6%) |
| Sept 2021 | - | -42.08%(-5.0%) |
| June 2021 | - | -44.30%(-7.4%) |
| Mar 2021 | - | -47.84%(-4.0%) |
| Dec 2020 | -52.07% | -49.81%(-6.8%) |
| Sept 2020 | - | -53.42%(-3.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2020 | - | -55.36%(+2.6%) |
| Mar 2020 | - | -53.94%(+8.2%) |
| Dec 2019 | -54.37%(+37.7%) | -49.83%(+10.1%) |
| Sept 2019 | - | -45.24%(+7.3%) |
| June 2019 | - | -42.16%(+5.4%) |
| Mar 2019 | - | -40.01%(-9.9%) |
| Dec 2018 | -39.49%(-44.0%) | -44.39%(-4.0%) |
| Sept 2018 | - | -46.22%(+1.9%) |
| June 2018 | - | -45.34%(-50.7%) |
| Mar 2018 | - | -92.05%(+30.5%) |
| Dec 2017 | -70.53%(-32.4%) | -70.53% |
| Dec 2016 | -104.30% | - |
FAQ
- What is Magenta Therapeutics annual return on equity?
- What is the all time high annual ROE for Magenta Therapeutics?
- What is Magenta Therapeutics annual ROE year-on-year change?
- What is Magenta Therapeutics quarterly return on equity?
- What is the all time high quarterly ROE for Magenta Therapeutics?
- What is Magenta Therapeutics quarterly ROE year-on-year change?
What is Magenta Therapeutics annual return on equity?
The current annual ROE of MGTA is -72.16%
What is the all time high annual ROE for Magenta Therapeutics?
Magenta Therapeutics all-time high annual return on equity is -39.49%
What is Magenta Therapeutics annual ROE year-on-year change?
Over the past year, MGTA annual return on equity has changed by -30.96% (-75.15%)
What is Magenta Therapeutics quarterly return on equity?
The current quarterly ROE of MGTA is -71.92%
What is the all time high quarterly ROE for Magenta Therapeutics?
Magenta Therapeutics all-time high quarterly return on equity is -40.01%
What is Magenta Therapeutics quarterly ROE year-on-year change?
Over the past year, MGTA quarterly return on equity has changed by -24.52% (-51.73%)